Impact of Microvolt T-wave Alternans on Malignant Arrhythmia Occurrence and Mortality in Patients with Congestive Heart Failure: Single-Centre Study

Authors

KŘIVAN Lubomír ČAPEK Bronislav LOKAJ Petr KOZÁK Milan SEPŠI Milan BUREŠOVÁ Lucie VLAŠÍNOVÁ Jitka ŠPINAR Jindřich

Year of publication 2012
Type Article in Periodical
Magazine / Source EUROPEAN JOURNAL OF CARDIOVASCULAR MEDICINE
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.5083/ejcm.20424884.82
Field Cardiovascular diseases incl. cardiosurgery
Keywords microvolt T-wave alternans; MTWA; malignant arrhythmia; CAD; DCMP
Attached files
Description The aim of this study was to assess the relation between microvolt T-wave alternans (MTWA) with malignant arrhythmia occurrence and mortality in patients with ventricular systolic function < 40% due to ischemic (CAD) or nonischemic cardiomyopathy (DCMP). Background: The predictive value of T-wave alternans for malignant arrhythmias in patients with congestive heart failure (CHF) is controversial. Methods: In a single-centre, prospective, observational study-including patients with CHF of ischemic and nonischemic aetiology we assessed the prognostic value of MTWA for malignant arrhythmias and total mortality. Results: This study included 155 patients; aetiology of CHF was CAD in 67.7%, and DCMP in 32.3%. Mean left ventricular ejection fraction (LVEF) was 29%. MTWA results were 38.1% positive, 40.6% negative, and 19.4% indeterminate. Over the median follow-up of 33.8 months, 13 deaths (7 cardiac and 6 noncardiac) were observed. The death rate in MTWA-negative patients did not significantly differ from that in MTWA-non negative patients (p = 0.203). There was also no difference in death rate between CAD and DCMP patients (p = 0.211). In only CAD patients, nonnegative MTWA predicted significantly higher occurrence of malignant arrhythmias (p = 0.033). This correlation was not significant for the total group (p = 0.100), or for the DCMP subgroup (p = 1.000). Conclusions: The negative predictive value of MTWA for malignant arrhythmias was 79.4%. Significant reduction of malignant arrhythmias in MTWA-negative patients was valid only in the CAD subgroup. The impact of MTWA on mortality was not significant.

You are running an old browser version. We recommend updating your browser to its latest version.

More info